Low Dose Alemtuzumab for Consolidation and Maintenance of Patients With B-Cell Chronic Lymphocytic Leukemia
Clinical trial NCT00336206 · UNKNOWN
Trial details
- NCT number
- NCT00336206
- Sponsor
- Tawam Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.